The American Journal of Medicine
Volume 69, Issue 6 , Pages 828-832, December 1980

Pregnancy outcome following cancer chemotherapy

  • Julie Blatt, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Dr. Julie Blatt, Pediatric Oncology Branch, National Cancer Institute, Bldg. 10, Room 3B12, Bethesda, Maryland 20205.
    • ,
  • John J. Mulvihill, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • ,
  • John L. Ziegler, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • ,
  • Robert C. Young, M.D., F.A.C.P.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • ,
  • David G. Poplack, M.D.

      Affiliations

    • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205, USA
    • Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205, USA

Accepted 6 June 1980.

The outcome of pregnancies of patients who received aggressive chemotherapy was examined. Of 448 patients screened, 30 had 12 abortions (10 elective and two spontaneous) and 28 live births. Follow-up of off spring revealed no major malformations. In addition, growth, development and school performance were normal. These results support the contention that chemotherapy administered to women prior to gestation or after the first trimester may result in normal births in the majority of cases. Moreover, the available data suggest that chemotherapy given to men at or prior to the time of conception does not appear to result in fetal damage. These results may be of value in counseling cancer patients regarding risks to their offspring.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9343(80)80007-6

The American Journal of Medicine
Volume 69, Issue 6 , Pages 828-832, December 1980

Article Tools